A Study of LY4175408 in Participants With Advanced Cancer
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
Exscientia AI Limited
Conjupro Biotherapeutics, Inc.
Sotio Biotech Inc.
National Cancer Institute (NCI)
BeOne Medicines
NiKang Therapeutics, Inc.
MacroGenics
SystImmune Inc.
SN BioScience
Incyte Corporation
NiKang Therapeutics, Inc.
Pfizer
University of Virginia
Incyte Corporation
Theratechnologies
Inspirna, Inc.
BeiGene
Carisma Therapeutics Inc
Vincerx Pharma, Inc.
AstraZeneca
Xencor, Inc.
Advaxis, Inc.
Zhejiang University
University of Florida
MacroGenics
SCRI Development Innovations, LLC
AstraZeneca
Fate Therapeutics
Xencor, Inc.
Xencor, Inc.
AbbVie
AbbVie
Incyte Corporation
Spectrum Pharmaceuticals, Inc
Incyte Corporation
AstraZeneca
Abramson Cancer Center at Penn Medicine
Celgene
PharmaMar
Canadian Cancer Trials Group
Takeda
Oncology Institute of Southern Switzerland
Pfizer
Merrimack Pharmaceuticals
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Santa Maria Biotherapeutics
University of Southern California